Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0022 Transporter Info | ||||
| Gene Name | SLC15A2 | ||||
| Transporter Name | Peptide transporter 2 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Bestatin Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 72172 | ||||
| Docking Score | -8.927 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C16H24N2O4 | ||||
| Molecular Weight | 308.37 | ||||
| Canonical SMILES |
CC(C)C[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](CC1=CC=CC=C1)N)O
|
||||
| InChI |
InChI=1S/C16H24N2O4/c1-10(2)8-13(16(21)22)18-15(20)14(19)12(17)9-11-6-4-3-5-7-11/h3-7,10,12-14,19H,8-9,17H2,1-2H3,(H,18,20)(H,21,22)/t12-,13+,14+/m1/s1
|
||||
| InChIKey | VGGGPCQERPFHOB-RDBSUJKOSA-N | ||||
| Pharmaceutical Properties | Xlogp | -1 | Rotatable Bond Count | 8 | |
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 5 | ||
| Xenobiotic Name | Cefepime Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 5479537 | ||||
| Docking Score | -8.878 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C19H24N6O5S2 | ||||
| Molecular Weight | 480.6 | ||||
| Canonical SMILES |
C[N+]1(CCCC1)CC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)SC2)C(=O)[O-]
|
||||
| InChI |
InChI=1S/C19H24N6O5S2/c1-25(5-3-4-6-25)7-10-8-31-17-13(16(27)24(17)14(10)18(28)29)22-15(26)12(23-30-2)11-9-32-19(20)21-11/h9,13,17H,3-8H2,1-2H3,(H3-,20,21,22,26,28,29)/b23-12-/t13-,17-/m1/s1
|
||||
| InChIKey | HVFLCNVBZFFHBT-ZKDACBOMSA-N | ||||
| Pharmaceutical Properties | Xlogp | -0.1 | Rotatable Bond Count | 6 | |
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 10 | ||
| Xenobiotic Name | Cefotaxime Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 5742673 | ||||
| Docking Score | -8.791 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C16H17N5O7S2 | ||||
| Molecular Weight | 455.5 | ||||
| Canonical SMILES |
CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\OC)/C3=CSC(=N3)N)SC1)C(=O)O
|
||||
| InChI |
InChI=1S/C16H17N5O7S2/c1-6(22)28-3-7-4-29-14-10(13(24)21(14)11(7)15(25)26)19-12(23)9(20-27-2)8-5-30-16(17)18-8/h5,10,14H,3-4H2,1-2H3,(H2,17,18)(H,19,23)(H,25,26)/b20-9-/t10-,14-/m1/s1
|
||||
| InChIKey | GPRBEKHLDVQUJE-QSWIMTSFSA-N | ||||
| Pharmaceutical Properties | Xlogp | -1.4 | Rotatable Bond Count | 8 | |
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 12 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.